Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Johnson & Johnson’s current trading price is -7.97% away from its 52-week high, while its distance from the 52-week low is 11.21%. The stock’s price range during this period has varied between $140.68 and $169.99. The company, active in the Healthcare sector, saw a trading volume of around 5.06 million for the day, considerably lower average daily volume of 9.19 million observed over the last three months.
Johnson & Johnson’s stock has seen a smooth market performance.
How Financial Performance Impacts Market Capitalization
Johnson & Johnson (JNJ) has experienced a quarterly decline of -5.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 376.43B and boasts a workforce of 138100 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
How JNJ’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for JNJ stands at 0.67. Similarly, the long-term debt-to-equity ratio is also 0.49.
JNJ Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 8.18%. However, over the past six months, we’ve seen a weaker performance of 4.63%. The price of JNJ fallen by 1.45% over the last 30 days. And in the last five days, it has surged by 1.31%.